Publications / White Papers

Non-invasive Quantification of Fatty Liver Disease

Jennifer Dolan Fox, Ph.D.; 1 Sep 2015

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatisis (NASH) are emerging as the most prevalent causes of liver disease in Western countries…

Immunotherapy – Concept Turned Reality

Jennifer Dolan Fox, Ph.D.; 20 Jul 2015

While using the body’s own immune system as a therapeutic approach to fight cancer is not a new concept in oncology, recent successes in clinical studies are making immunotherapy a reality…

Blood Pressure Evaluation During Early Phase Trials

Daniel B. Goodman, MD, Michael A. Weber, MD; 3 Nov 2014

As we know, more attention is being paid to blood pressure (BP) effects in new chemical entities under development for non-hypertension indications…

ECHO Inter/Intra-Reader Variability

Goodman DB and Voloshko P; 4 Sep 2014

BioTelemetry Research performed a blinded reading to define the variability between inter-reader and intra-reader assessments…


Body Composition in Clinical Trials – From BMI to MRI

join our Vice President of Musculoskeletal and Metabolic Imaging, Jonathan Riek, PhD, and AMRA’s Chief Scientific Officer & Co-Founder, Olof Dahlqvist Leinhard, PhD, as they present alternative, noninvasive imaging methods to determine body composition.

Feb 13, 2018 | 11:00 AM

Key Takeaways from the New CSRC/FDA Meeting on Cardiac Safety and Cardiovascular Safety Issues in Oncology Drug Development

Join Polina Voloshko, MD, Chief Medical Officer and Daniel Goodman, MD, Vice President and Medical Director, to learn about the updates from the new CSRC/FDA meeting on cardiac safety and cardiovascular safety issues in oncology drug development to optimize your clinical trial.

Nov 1, 2017 | 11:00 AM

Optimize the Imaging in Clinical Trials by Aligning Operational Excellence and Scientific Expertise

Join Ed Ashton, Ph.D., Vice President of Oncology Imaging and Danielle Lewis, M.S., PMP, Global Operations Account Manager, for an educational webinar discussing real-world scientific and operational examples of errors that can occur during your imaging clinical trial and how you can prevent them.

Sep 13, 2017 | 11:00 AM

Assessing NASH: Discover the Non-invasive Techniques

Join Richard Ehman, MD from the Mayo Clinic and BioTelemetry Research’s Jonathan Riek, PhD, VP, Musculoskeletal and Metabolic Imaging as they discuss non-invasive ways to assess NASH using imaging, including proton density fat fraction (PDFF), T1 relaxometry, magnetic resonance elastography (MRE), and the latest advances in MRE.

Apr 13, 2017 | 11:00 AM

Managing Multi-protocol Programs & Building Efficient Partnerships

Join Svetlana Kolchinsky, MD, Director of Project Operations, as she discusses how to manage multi-protocol programs and build efficiencies while being a good partner. Key topics include next level planning for risk management and project/program oversight, successful project delivery and lessons learned.

Nov 3, 2016 | 11:00 AM

Advanced Imaging in Oncology

In this free webinar, industry experts Edward Ashton, PhD and Polina Voloshko, MD will discuss the growing range of imaging modalities and analysis methods that are available for use in your clinical trials during oncology drug development.

Aug 24, 2016 | 11:00 AM

Dynamic Repolarization Analysis: A New Phase I Cardiac Safety Paradigm

BioTelemetry Research is proposing a service offering for evaluation of cardiac repolarization in early human trials, novel to the industry, called Dynamic Repolarization Analysis.

Oct 14, 2015 | 11:00 AM

Medical Imaging: Maximizing Efficacy and Safety in Oncology Clinical Trials

In this free webinar, industry experts Sandra Chica, MD and Polina Voloshko, MD aim to describe novel medical imaging approaches and methodologies to help sponsors maximize clinical trial efficiency along the development pathway.

Jun 24, 2015 | 11:00 AM